A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
An overview of pleiotropic effect of statins in cardiovascular disease
2018
Pharmacy & Pharmacology International Journal
HMG CoA-reductase (3-hydroxy-3-methylglutaryl coenzyme A reductase) inhibitors, also called statins, are at present exerting an effect on the therapeutic treatment decision for hypercholesterolemia. Hypercholesterolemia is a known risk factor for cardiovascular malady, and statin treatment has prompted a significant decline in grimness and mortality from undesirable cardiovascular events, stroke, and fringe blood vessel malady. Notwithstanding accomplishing a remedial diminishing in serum
doi:10.15406/ppij.2018.06.00214
fatcat:uabglg55wrc3lkvwgks4kkytma